Susquehanna Portfolio Strategies, LLC Treace Medical Concepts, Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $6.3 Trillion
- Q3 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 13,925 shares of TMCI stock, worth $42,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,925Holding current value
$42,192% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TMCI
# of Institutions
122Shares Held
58.9MCall Options Held
0Put Options Held
0-
Cibc Bancorp Usa Inc. Chicago, IL18.2MShares$55.2 Million0.15% of portfolio
-
Armistice Capital, LLC New York, NY6.32MShares$19.1 Million0.65% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$12.3 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.63MShares$11 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$8.28 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $168M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...